trial

Cognitive Strategies in Early Psychosis 2

NCTId NCT07263022
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 3 · Not Yet Recruiting
Enrollment 24 (estimated)
Sponsored by University of Minnesota
Primary completion 2030-04-30
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 3
Status
Not Yet Recruiting
Enrollment
24 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Triple
Start
2026-07-07
Primary completion
2030-04-30
Eligibility
ALL · 18 Years · 35 Years

Interventions & indications

Drugs
modafinilD-serine solution

Sponsors

University of MinnesotaLead Sponsor
National Institute of Mental Health (NIMH)Collaborator

Investigators

2
Sophia Vinogradov, MDPrincipal Investigator
Caroline Cellard, Ph.DPrincipal Investigator

Sites

0 total

Linked catalysts

1
Cognitive Strategies in Early Psychosis 2 — primary completion2030-04-30

Facts & assertions

4 sourced
Enrollment
24
Phase
PHASE3
Primary Completion Date
2030-04-30
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
modafinil
drug
D-serine solution
drug
lead_sponsor
University of Minnesota
company
collaborator
National Institute of Mental Health (NIMH)
company
indication
Schizophreniform Disorder
indication
Major Depressive Disorder With Psychotic Features
indication
Schizoaffective Disorder
indication
investigator
Sophia Vinogradov, MD
person
Caroline Cellard, Ph.D
person